Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death
worldwide. Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol …

Early detection of hepatocellular carcinoma (HCC) leads to improved survival; however,
current early detection strategies for HCC surveillance are ineffective. Thus, there has been …

Background: The GALAD score is a serum biomarker–based model that predicts the
probability of having hepatocellular carcinoma (HCC) in patients with chronic liver disease …

Introduction: Hepatocellular carcinoma (HCC) is the sixth most commonly diagnosed cancer
and the third leading cause of cancer death worldwide. While there has been rapid evolution …

Background The diagnosis performance of B-mode ultrasound (US) for focal liver lesions
(FLLs) is relatively limited. We aimed to develop a deep convolutional neural network of US …

High-throughput tests for early cancer detection can revolutionize public health and reduce
cancer morbidity and mortality. Here we show a DNA methylation signature for …

OBJECTIVE. The purpose of this study is to evaluate the per-patient diagnostic performance
of an abbreviated gadoxetic acid–enhanced MRI protocol for hepatocellular carcinoma …

Purpose To determine the proportion of untreated Liver Imaging Reporting and Data System
(LI-RADS) version 2014 category 2, 3, and 4 observations that progress, remain stable, or …

Aim To evaluate the diagnostic per-lesion performance of a simulated gadoxetate disodium-
enhanced abbreviated MRI (AMRI) in cirrhotic and chronic hepatitis B (CHB) patients for …

OBJECTIVE. This systematic review presents evidence-based consensus statements as
reported by a multidisciplinary expert panel (six abdominal radiologists, four hepatobiliary …